Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+33.4%
5Y CAGR+28.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+33.4%/yr
Annual compound
5Y CAGR
+28.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $85.10M | +27.5% |
| 2024 | $66.73M | +23.4% |
| 2023 | $54.08M | +50.8% |
| 2022 | $35.87M | +72.3% |
| 2021 | $20.82M | -14.4% |
| 2020 | $24.31M | - |